The Transthyretin Amyloidosis Market is a critical sector within healthcare dedicated to addressing a rare and progressive disorder characterized by the deposition of abnormal transthyretin protein in various tissues, leading to organ dysfunction. This market encompasses diagnostic tools, disease-modifying therapies, and supportive care measures for individuals affected by transthyretin...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian